SOSAFE
SoSafe, Europe’s largest security awareness and human risk management vendor, has appointed seasoned HR executive Laura Ryan as Chief People Officer to support the organisation as they continue to scale operations internationally in the face of rising global cyber security threats.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240604322632/en/
Laura Ryan appointed as new Chief People Officer at largest security awareness and human risk management platform SoSafe. (Photo: Business Wire)
Laura will lead SoSafe’s people function, overseeing the development of a best-in-class team to help deliver the company’s next chapter of strategic growth. She will manage human resources, people and talent, workspace and community, and operations, acting as an engine to accelerate the company’s mission and long-term vision to strengthen digital self-defence.
With over 20 years of hands-on experience in the technology and financial services industries, Laura has actively supported the evolution of HR functions. Prior to joining SoSafe, she worked almost nine years at Dropbox, most recently as Vice President Global HR Business Partnering. Prior to this, Laura spent over five years at Google and over seven years in Financial Services in a number of HR roles, honing her HR craft.
Laura Ryan, incoming Chief People Officer at SoSafe: “Throughout my career I've been passionate about scaling organisations, helping companies achieve this by fostering innovation and creating workplaces that inspire people to do their best work. SoSafe is working in an extremely interesting market with very strong dynamics: Cybercrime is the biggest threat to organisations and SoSafe delivers a human-centric solution based on psychology. This gives the company and the team a very strong purpose and I am very excited to contribute to their mission to empower people facing digital threats.”
SoSafe is currently leading the category evolution from security awareness and training to human risk management through product innovation, accelerating its sustainable growth. Since the beginning of 2022, they have grown from 180 employees in Cologne, Germany, to 500 employees across nine locations in Europe with around 100 open positions, recently adding two additional office hubs in Dublin, Ireland, and Chemnitz, Germany.
Dr Niklas Hellemann, CEO of SoSafe: "One of the pillars of our success is the excellence of our people - we are proud to have an outstanding team to drive our ambitious plans. Laura brings a wealth of experience in fast-paced, multi-cultural organisations and has proven her ability to build and lead people divisions in high growth technology companies. I am very excited to have her join our management team and look forward to working with her to drive further growth for the business.”
Laura's appointment follows a series of senior hires to strengthen the company's expertise.:
- Megan Brown joins as Vice President of Global Partnerships, bringing more than 15 years of sales experience at LogicGate, Checkster and CareerBuilder to lead SoSafe's plans to expand its channel sales through international partnerships.
- Gina Dragulin joins as Vice President of Product Marketing to ensure that SoSafe's product innovations are brought to life and their customers get highest value. Prior to joining SoSafe, she worked for Miro, Microsoft and other tech companies while leading various marketing functions.
- Thomas Owen joins as Chief Information Security Officer, bringing with him a wealth of experience in the security industry from companies such as Grafana Labs, iloomi and Snyk.
About SoSafe
SoSafe, founded by a team of behavioural scientists and technology experts, is the largest security awareness and human risk management vendor based in Europe. SoSafe is empowering over 4700 customers worldwide to effectively mitigate cyber risk. With a unique human-centric approach grounded in behavioural science, SoSafe enhances secure behaviour across organizations, making it intuitive and second nature. The platform is designed to strengthen digital self-defence by creating robust security cultures that actively involve employees in mitigating human risks. By leveraging psychology and advanced technology and AI, it enables security professionals to effectively identify, prioritize, manage, and ultimately reduce their human risk. The SoSafe team now consists of more than 500 employees in nice locations: Cologne (headquarters), Amsterdam, Berlin, Chemnitz, Dublin, London, Paris, Lisbon, and Munich.
Website: www.sosafe-awareness.com/
LinkedIn: www.linkedin.com/company/sosafe-cyber-security/mycompany/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240604322632/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom